Preclinical and early human data indicate BriLife may confer enhanced immunity against Delta variant
Filing for WHO Emergency Use Authorisation this month
Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series
All India Institute of Ayurveda hosts ministers and showcase their achievements
AstraZeneca, Sinopharm and Moderna were part of the study
Ayush Ministry will conduct the study along with the UK’s London School of Hygiene and Tropical Medicine
The companies anticipate clinical studies to begin in August, subject to regulatory approvals
The drug is used with other HIV medications to help control HIV infection and it helps to decrease the amount of HIV in one’s body so that the immune system can work better
Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28.
Subscribe To Our Newsletter & Stay Updated
